Elicio Therapeutics, Inc. (ELTX)
Elicio Therapeutics will go public soon, but the exact IPO date is still unknown.
IPO Price Range
$12.00 - $14.00
Shares Offered
3,076,924
Deal Size
$40.00M
Income Statement (Annual)
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2020 | 2019 |
|---|---|---|
| Selling, General & Admin
|
3 | 2.8 |
| Research & Development
|
12.72 | 9.54 |
| Operating Expenses
|
15.72 | 12.34 |
| Operating Income
|
-15.72 | -12.34 |
| Other Expense / Income
|
-0.01 | -0.08 |
| Pretax Income
|
-15.71 | -12.26 |
| Net Income
|
-15.71 | -12.26 |
| Net Income Common
|
-15.71 | -12.26 |
| EBITDA
|
-15.52 | -12.15 |
| Depreciation & Amortization
|
0.19 | 0.11 |
| EBIT
|
-15.71 | -12.26 |
Source: IPO financials are sourced from
S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).